Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09XKO
|
|||
| Former ID |
DIB010420
|
|||
| Drug Name |
KD-101
|
|||
| Indication | Metabolic disorder [ICD-11: 5C50-5D2Z; ICD-10: E70-E90; ICD-9: 270-279] | Phase 1 | [1] | |
| Company |
Kwang Dong Pharmaceutical Co Ltd
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01979380) Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male Subjects. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.